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Abstract
Arterial wall thickening, stimulated by low-grade systemic inflammation, underlies many cardiovascular events. As diet is a significant moderator of
systemic inflammation, the dietary inflammatory index (DIITM) has recently been devised to assess the overall inflammatory potential of an individual’s
diet. The primary objective of this study was to assess the association of the DII with common carotid artery–intima-media thickness (CCA–IMT) and
carotid plaques. To substantiate the clinical importance of these findings we assessed the relationship of DII score with atherosclerotic vascular disease
(ASVD)-related mortality, ischaemic cerebrovascular disease (CVA)-related mortality and ischaemic heart disease (IHD)-related mortality more. The
study was conducted in Western Australian women aged over 70 years (n 1304). Dietary data derived from a validated FFQ (completed at baseline)
were used to calculate a DII score for each individual. In multivariable-adjusted models, DII scores were associated with sub-clinical atherosclerosis:
a 1 SD (2·13 units) higher DII score was associated with a 0·013-mm higher mean CCA–IMT (P=0·016) and a 0·016-mm higher maximum CCA–IMT
(P=0·008), measured at 36 months. No relationship was seen between DII score and carotid plaque severity. There were 269 deaths during follow-up.
High DII scores were positively associated with ASVD-related death (per SD, hazard ratio (HR): 1·36; 95% CI 1·15, 1·60), CVA-related death (per SD, HR:
1·30; 95% CI 1·00, 1·69) and IHD-related death (per SD, HR: 1·40; 95% CI 1·13, 1·75). These results support the hypothesis that a pro-inflammatory diet
increases systemic inflammation leading to development and progression of atherosclerosis and eventual ASVD-related death.
Key words: Dietary inflammatory index: Atherosclerotic vascular disease: Intima-media thickness: Prospective cohort studies
Inflammation is strongly associated with many chronic condi-
tions including CVD(1). Diet is a significant moderator of systemic
inflammation with some foods and nutrients possessing
anti-inflammatory properties and others pro-inflammatory
properties(2). Diets rich in fruits, vegetables and whole grain
foods are linked with lower circulating concentrations of
inflammatory biomarkers(3). The dietary inflammatory index
(DIITM) was created to assess the overall inflammatory potential
of an individual’s diet by relating particular food intakes to
inflammatory biomarkers (C-reactive protein, IL1β, IL4, IL6, IL10
Abbreviations: ASVD, atherosclerotic vascular disease; CCA–IMT, common carotid artery–intima-media thickness; CVA, cerebrovascular disease; DII, dietary
inflammatory index; HR, hazard ratio; ICD, International Classification of Disease; IHD, ischaemic heart disease.
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and TNF-α)(2). It has allowed testing of the hypothesis that
more pro-inflammatory diets, indicated by higher DII scores, will
be associated with chronic diseases such as CVD(4). The DII
can be calculated from various dietary assessment tools, the
most common being FFQ(2,4,5). Several studies have found
positive associations between DII scores and CVD mortality(6–8),
however to date no studies have explored the association
between the DII and measures of sub-clinical atherosclerosis.
Atherosclerosis is the primary cause of CVD(9) and its develop-
ment and progression is linked to inflammation(10). Sub-clinical
atherosclerosis can be assessed in humans by measuring
common carotid artery–intima-media thickness (CCA–IMT)
and carotid plaques. Correspondingly, CCA–IMT, and carotid
plaques are independently associated with stroke risk(11).
CCA–IMT is also an independent predictor of ischaemic heart
disease (IHD)(12).
The primary objective of this study was to assess the
association of DII scores with CCA–IMT and severe
carotid plaques in a cohort of women aged ≥70 years. We also
aimed to explore the relationship of DII with atherosclerotic
vascular disease (ASVD)-related mortality, and the subgroups




Data were obtained from a cohort of women aged 70 years and
over, who were originally recruited in 1998 to a 5-year, double-
blind, randomised control trial of oral Ca supplementation to
prevent osteoporotic fracture; the Calcium Intake Fracture Out-
come Study, which is described in detail elsewhere(13). In brief,
1500 women were recruited from the Western Australian general
population by mail using the Electoral Roll, enrolment on which is
a requirement of Australian citizenship. All participants were
ambulatory, had an expected survival beyond 5 years and were
not receiving any medication known to affect bone metabolism.
In the subsequent 5 years following inclusion in the study, parti-
cipants received 1·2g of elemental Ca as calcium carbonate daily
or a matching placebo. We have previously shown no effect of
Ca treatment on any measure of carotid atherosclerosis in this
cohort(14). Participants were followed for a further 10 years as part
of the Longitudinal Study of Aging in Women. After excluding
participants who did not complete a FFQ at baseline and those
with implausible energy intakes <2100kJ/d (500kcal/d) or
>14700kJ/d (3500kcal/d), 1468 participants remained (Fig. 1).
Participants with a history of pre-existing diabetes, myocardial
Participants assessed for eligibility
(n 1500)
Assessed for history of myocardial
infarction, coronary revascularisation,




• Implausible energy intakes
Excluded (n 164) 
• History of myocardial infarction
• History of coronary revascularisation
• History of stroke
• Pre-existing diabetes
3 years  
CCA-IMT analysis (n 1010)
Plaque analysis (n 1028)
15 years 
ASVD-related mortality (n 269)
CVA-related mortality (n 107)
IHD-related mortality (n 150) 
Baseline
ASVD-CVA- and IHD-related mortality
analysis (n 1304) 
Fig. 1. Consort flow diagram. ASVD, atherosclerotic vascular disease; CVA, cerebrovascular disease; IHD, ischaemic heart disease; CCA–IMT, common carotid
artery–intima-media thickness.
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infarction, stroke and/or coronary revascularization were exclu-
ded (n 164), leaving 1304 for the mortality analysis. Of these
participants 1010 and 1028 participants had CCA–IMT and plaque
measurements taken at 36 months (2001), respectively (Fig. 1).
The participants provided their previous medical history and
current medications verified by their General Practitioner. These
data were coded using the International Classification of
Primary Care-Plus method and were used to determine the
presence of pre-existing diabetes (T89001–90009). This coding
methodology allows aggregation of different terms for similar
pathological entities as defined by the International Classifica-
tion of Disease (ICD) coding system.
History of myocardial infarction, stroke or coronary
revascularisation at baseline was determined using linked data
via the Western Australian Data Linkage System. Primary
hospital discharge diagnosis codes from 1980–1998 for myo-
cardial infarction included ICD-9-CM code 410 and for
stroke included ICD-9-CM codes 430-434(15). Coronary revas-
cularisation included coronary artery bypass grafting
(CABG); and/or percutaneous transluminal coronary angio-
plasty (PTCA). CABG procedure codes included: ICD-9-CM
codes 36.1–36.19; and Australian classification of health
interventions (ACHI) codes 38497, 38500, 38503, 90201 in
procedure codes (1–20). PTCA procedure codes included:
ICD-9-CM codes 36.0–36.07; and ACHI codes 35310–00,
35310–01, 35310–02, 38306–00, 38306–01, 38306–02, 35304–00,
35305–00, 38300–00, 38303–00, 35335–00, 35338–00, 35338–01,
35341–00, 35344–00, 35344–01, 38309–00, 38312–00, 38312–01,
38315–00, 38318–00, 38318–01, angioplasty with or without
stent on open chest 35310–03, 35310–04, 35310–05, 35304–01,
35305–01, 3850500, 38306–03, 38306–04, 38306–05, 38300–01,
38303–01.
At baseline, written informed consent was obtained from all
participants for the study and for the follow-up of electronic
health records. The Human Ethics Committee of the University
of Western Australia approved the study protocol and consent
form (approval no. 05/06/004/H50). The Human Research
Ethics Committee of the Western Australian Department of
Health also approved the data linkage study (approval
no. #2009/24).
Dietary assessment and calculation of the dietary
inflammatory index score
Baseline (1998) dietary intake was assessed using a validated
semi-quantitative FFQ developed by the Cancer Council of
Victoria(16). Energy and nutrient intakes were estimated
based on frequency of consumption and usual portion size(17).
Values from the FFQ were used to calculate a DII score for
each individual. The thirty-one food parameters obtained from
the FFQ and used to calculate the DII score are presented
in Table 1. The DII score is based on a literature review of
1943 articles published up until 2010 linking dietary compo-
nents to six markers of inflammation. A comprehensive
description detailing development of the DII score is
available elsewhere(2,18). In brief, to calculate DII score for the
participants in this study, the mean intake of every food
variable was transformed with standardised values from a
world database to obtain a ‘z score’. To minimise the effect of
‘right skewing’, the ‘z’ scores were converted to a proportion
and then centred by doubling the proportion and subtracting 1.
This score was then multiplied by the respective food
parameter-specific inflammatory effect score derived from
the literature review. All of the food parameter-specific DII
scores were summed to create the overall DII score for
each individual.
Common carotid artery–intima-media thickness and carotid
focal plaques
CCA–IMT and the presence of carotid focal plaques were
determined at year 3 (2001) as described in detail elsewhere(19).
In brief, six images taken from three different angles (antero-
lateral, lateral and posterolateral) were examined and the CCA–
IMT from each image was averaged to give an overall mean
CCA–IMT and maximum CCA–IMT. A short‐term precision
study with repeat IMT measurements yielded a CV of 5·98%, as
described previously(20). The complete carotid tree (common
carotid artery, carotid bulb, internal and external carotid) was
then examined for the presence of focal plaque, defined as an
area of focal increased thickness (≥1mm) of the intima-media
layer. Severity of carotid plaque was further dichotomised by
the degree of carotid stenosis as either none to minimal (<25%)
or moderate to high (≥25%)(21).
Table 1. Thirty-one food parameters obtained from the FFQ and used to
calculate the dietary inflammatory index score
Food parameters Overall inflammatory effect score
Alcohol (g) − 0·278
β-Carotene (mg) − 0·584
Carbohydrate (g) 0·097
Cholesterol (mg) 0·110
Total fat (g) 0·298
Fibre (g) − 0·663
Folic acid (mg) − 0·190
Garlic (g) − 0·412
Fe (mg) 0·032
Mg (mg) − 0·484
MUFA (g) − 0·009
Niacin (mg) − 0·246
n-3 Fatty acids (g) − 0·436
n-6 Fatty acids (g) − 0·159
Onion (g) − 0·301
Protein (g) 0·049
PUFA (g) − 0·337
Riboflavin (mg) − 0·068
SFA (g) 0·373
Thiamin (mg) − 0·098
Trans-fat (g) 0·229
Vitamin A (RE) − 0·401
Vitamin C (mg) − 0·424
Vitamin E (mg) − 0·419
Zn (mg) − 0·313
Flavan-3-ol (mg) − 0·415
Flavones (mg) − 0·616
Flavonols (mg) − 0·467
Flavonones (mg) − 0·250
Anthocyanidins (mg) − 0·131
Isoflavones (mg) − 0·593
RE, retinol equivalent.
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15-year atherosclerotic vascular disease- cerebrovascular
disease- and ischaemic heart disease-related mortality
Coded multiple cause of death data over a 15-year period were
retrieved from linked mortality data via the Western Australian
Data Linkage System. Causes of death were obtained from the
coded death certificate using information in Parts 1 and 2 of
the death certificate, or all diagnosis text fields from the
death certificate where coded deaths were not yet available.
ASVD deaths were defined using diagnosis codes from the
ICD-9-CM(15) and the International Statistical Classification of
Diseases and Related Health Problems, 10th Revision, Australian
Modification (ICD-10-AM)(22). ASVD death diagnosis codes
included as IHD (ICD-9-CM codes 410–414 and ICD-10-AM
codes I20-I25); heart failure (ICD-9-CM code 428 and ICD-10-AM
code I50); CVA, excluding haemorrhage (ICD-9-CM codes
433–438 and ICD-10-AM codes I63-I69, G45.9); and peripheral
arterial disease (ICD-9-CM codes 440–444 and ICD-10-AM codes
I70-I74). Two subgroups of ASVD were also analysed: CVA
excluding haemorrhage and IHD (ICD codes as above).
Covariates
Baseline questionnaires were used to determine values for
potential confounding variables including age, socioeconomic
status (SES), use of low-dose aspirin, use of antihypertensive
medication, use of statins and current or previous smoking.
Weight was assessed using digital scales with participants
wearing light clothes and no shoes. Height was assessed using a
stadiometer and the BMI was calculated in kg/m2 at baseline.
Total energy intakes were estimated from the FFQ. For physical
activity, the women filled in a validated questionnaire that
allowed estimation of energy used during exercise in kJ/d with
the use of published energy costs of specific activities(23). The
women were asked whether they participated in any sports,
recreation or regular physical activity. Women who answered
‘no’ to this question received a score of 0 and women who
answered ‘yes’ were asked to list up to four forms of regular
physical activity undertaken in the past 3 months. Energy
expenditure (in kJ/d) for these activities was calculated with the
use of published energy costs. SES was estimated from the postal
code of the participant’s home address. SES was categorised as:
1, top 10% most disadvantaged; 2, highly disadvantaged;
3, high–medium disadvantaged; 4, medium–low disadvantage;
5, low disadvantage; 6, top 10% least disadvantaged. Smoking
status was coded as non-smoker or ex-smoker/current smoker
(there were only three current smokers) if a participant had ever
consumed more than one cigarette per day for more than
3 months during the past. Previous ASVD was determined from
primary discharge diagnoses from hospital records (1980–1998)
using the ICD codes described previously(24).
Statistical analysis
A protocol for the statistical analysis of the data was established
before the analysis began. Analyses were undertaken using IBM
SPSS® Statistics version 21 (2012; IBM Corp.) and SAS® 9.2 (SAS
Institute). Statistical significance was set at P≤ 0·05 (two-tailed)
for all tests. DII score was assessed as a continuous variable and
a categorical variable when categorised into quartiles:
Q1 (−6·140, −1·370); Q2 (−1·371, 0·160); Q3 (0·161, 1·720);
Q4 (1·721, 5·800). Descriptive data are presented as mean
values and standard deviations for normally distributed con-
tinuous variables, medians and interquartile ranges for non-
normally distributed continuous variables and as numbers and
percentages for categorical variables. P values for the compar-
ison of baseline characteristics across DII score quartiles were
determined by ANOVA or the Kruskal–Wallis H test for con-
tinuous variables or χ2 tests for categorical variables. For all
subsequent analyses, two models were fit: (1) age-adjusted only
and (2) multivariable-adjusted (age, BMI, energy intake, energy
expended in physical activity, SES, use of low-dose aspirin, use
of antihypertensive medication, use of statins, current or pre-
vious smoking, prevalent ASVD and treatment code). The
relationship between mean and maximum CCA–IMT and DII
score as a continuous variable was assessed by linear regression
using age- and multivariable-adjusted models. We also com-
pared mean and maximum CCA–IMT scores across total DII
score quartiles using univariate ANCOVA, with Bonferroni’s
adjustment for multiple comparisons. The relationship between
atherosclerotic plaque severity and DII score, both as a con-
tinuous and as a categorical variable, was examined by binary
logistic regression using age- and multivariable-adjusted models.
Age- and multivariable-adjusted Cox proportional hazard ratios
(HR) and 95% CI of ASVD-, CVA- and IHD-related
mortality risk were computed across quartiles of the DII,
where the lowest (most anti-inflammatory) quartile was the
referent. We tested for evidence of a linear relationship using DII
score as a continuous variable in a separate Cox proportional
hazards model. Cox proportional hazards assumptions were
tested using log–log plots of the survival function v. time and
assessed for parallel appearance. To assess the extent of possible
reverse causality bias, we repeated all analyses after excluding all
ASVD, CVA and IHD deaths that occurred within the first
24 months.
Results
The DII scores were normally distributed, with a mean of 0·17
units and a SD of 2·13 units. The baseline characteristics of the
study population overall and stratified by DII score quartiles
(Q1 (−6·140, −1·370); Q2 (−1·371, 0·160); Q3 (0·161, 1·720);
Q4 (1·721, 5·800)) are shown in Table 2. There were 326 par-
ticipants in each quartile. At baseline, subjects in the lowest v.
the highest quartile of DII score had a higher energy intake and
a higher level of physical activity. The mean of mean CCA–IMT
was 0·779 (SD 0·128)mm (range: 0·423–2·078mm) and the
mean of maximum CCA–IMT was 0·923 (SD 0·151)mm
(range: 0·515–2·318mm). A total of 491 (47·9%) participants
had a focal plaque present and 137 (13·4%) participants had
moderate to high plaque severity (≥25% carotid stenosis).
Dietary inflammatory index and common carotid
artery–intima-media thickness
DII score was linearly associated with mean and maximum
CCA–IMT in age and multivariable-adjusted models (Table 3).








bridge.org/core . IP address: 71.70.64.242 , on 25 Jun 2020 at 12:05:51 , subject to the Cam
bridge Core term






A 1 SD (2·13 units) higher DII score was associated with a
0·013-mm (95% CI 0·002, 0·023) higher mean CCA–IMT and a
0·016-mm (95% CI 0·004, 0·028) higher maximum CCA–IMT
after multivariable adjustment for pre-specified baseline risk
factors.
The effect of diet-mediated inflammation was further
explored by assessing mean and maximum CCA–IMT across DII
score quartiles (Fig. 2). Participants with a DII score >1·721 (top
quartile) had a significantly higher CCA–IMT than participants
with a DII score ≤1·370 (bottom quartile) after multivariable
adjustment for pre-specified baseline risk factors ((mean
differences; mean CCA–IMT: 0·039mm; 95% CI 0·002, 0·077,
P= 0·03; maximum CCA–IMT: 0·047mm; 95% CI 0·003, 0·091,
P= 0·03)).
Dietary inflammatory index score and carotid focal plaques
Data were available on carotid focal plaques for 1026 partici-
pants, of which 13·6% had moderate to severe carotid stenosis
(≥25%). Neither DII score as a continuous nor as a categorical
covariate was a predictor of plaque severity in age- and
multivariable-adjusted models (Table 4).
Dietary inflammatory index score and 15-year
atherosclerotic vascular disease- cerebrovascular
disease- and ischaemic heart disease-related mortality
During 16 947 person-years of follow-up, 269 out of 1304
(20·7%) participants died from an ASVD-related cause. Of
these, 107 were related to ischaemic CVA and 150 were related
Table 2. Baseline characteristics of study population, stratified by dietary inflammatory index (DII) quartiles (Q), Longitudinal Study of Aging in Women,
Western Australia, 1998–2013
(Mean values and standard deviations; medians and interquartile ranges (IQR); mean values and standard deviations)
DII quartiles
Total Q1* Q2* Q3* Q4*
Characteristics n % n % n % n % n % P†
Age (years) 0·54
Mean 75·1 75·3 75·0 75·0 75·2
SD 2·7 2·6 2·7 2·7 2·8
BMI (kg/m2) 0·78
Mean 27·0 27·1 26·8 27·1 27·0
SD 4·6 4·6 4·3 4·6 5·0
Energy intake (1000 kJ/d) 0·01
Mean 7·1 9·0 7·6 6·4 5·6
SD 2·1 2·0 1·6 1·4 1·4
Physical activity (100 kJ/d) 0·01
Median 4·6 5·4 4·8 4·6 3·8
IQR 1·0–8·6 1·9–9·2 2·1–8·8 0–7·8 0–8·4
Socioeconomic status 0·99
Bottom 10% 46 3·6 13 4·1 12 3·7 10 3·1 11 3·4
Low 154 11·9 36 11·3 35 10·8 36 11·1 47 14·5
Low–medium 210 16·2 53 16·6 56 17·2 53 16·4 48 14·8
Medium–high 198 15·3 50 15·6 50 15·4 51 15·8 47 14·5
High 268 20·7 67 20·9 68 20·9 62 19·2 71 21·8
Top 10% 417 32·3 101 31·6 104 32·0 111 34·4 101 31·1
Low-dose aspirin use 232 17·8 64 19·6 43 13·2 61 18·7 64 19·6 0·09
Antihypertensive use 537 41·2 140 42·9 122 37·4 139 42·6 136 41·7 0·45
Statin use 209 16·0 63 19·3 46 14·1 47 14·4 53 16·3 0·24
Smoked ever 470 36·3 121 37·3 116 35·7 116 35·9 117 36·1 0·97
Prevalent ASVD 88 6·7 21 6·4 20 6·1 26 8·0 21 6·4 0·78
Ca treatment 677 52·0 179 54·9 175 53·8 164 50·3 159 48·8 0·35
ASVD, atherosclerotic vascular disease. Quartiles of DII: Q1 (−6·140, −1·370); Q2 (−1·371, 0·160); Q3 (0·161, 1·720); Q4 (1·721, 5·800).
* n 326.
† P value for the comparison between DII quartiles, by ANOVA, Kruskal–Wallis H test or χ2 test where appropriate.
Table 3. Associations between dietary inflammatory index, measured at baseline, and mean and maximum common carotid artery–
intima-media thickness (CCA–IMT) measured at year 3, Longitudinal Study of Aging in Women, Western Australia, 1998–2013*
(Unstandardised coefficients and 95% confidence intervals)
Age adjusted Multivariable adjusted†
Characteristics B 95% CI P B 95% CI P
CCA–IMT
Mean (per 1 SD) 0·012 0·004, 0·020 0·002 0·013 0·002, 0·023 0·016
Maximum (per 1 SD) 0·015 0·006, 0·024 0·002 0·016 0·004, 0·028 0·008
* SD (2·13 units).
† Linear regression models were multivariable adjusted for age, BMI, energy intake, energy expended in physical activity, socioeconomic status, use of low-
dose aspirin, use of antihypertensive medication, use of statins, current or previous smoking, prevalent atherosclerotic vascular disease and treatment.
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to IHD. Age-adjusted and multivariable-adjusted associations
between DII score and mortality are shown in Table 5. For
every 1 SD (2·13 units) increase in DII score, there was an
associated 36% higher risk of ASVD-related death (HR: 1·36;
95% CI 1·15, 1·60) in the multivariable-adjusted model. Simi-
larly, in multivariable-adjusted models, for every 1 SD increase in
DII score, there was an associated 30 and 40% higher risk of
CVA-related mortality (HR: 1·30; 95% CI 1·00, 1·69) and IHD-
related mortality (HR: 1·40; 95% CI 1·13, 1·75), respectively.
After adjustments for confounding risk factors, participants in
the highest (most pro-inflammatory) quartile of DII score were
at a higher risk of an ASVD- (HR: 2·02; 95% CI 1·30, 3·13), CVA-
(HR: 1·76; 95% CI 0·92, 3·40) or IHD-related (HR: 2·51; 95% CI
1·37, 4·62) cause of death in comparison to those in the lowest
quartile of the DII score, although this did not reach significance
for CVA-related mortality (P= 0·09). The multivariable-adjusted
survival outcomes for ASVD, CVA and IHD according to quar-
tiles of DII score are presented in Fig. 3(a)–(c).
Sensitivity analyses
Dietary inflammatory index score and 15-year atherosclerotic
vascular disease-related mortality. To assess the extent of
reverse causality bias, we excluded all ASVD, CVA and IHD
deaths that occurred within the first 24 months. This did not sig-
nificantly attenuate the relationship between DII score and ASVD
mortality (HR: 1·34; 95% CI 1·14, 1·58, P=0·001), CVA mortality
(HR: 1·30; 95% CI 1·00, 1·69, P= 0·049) and IHD mortality (HR:
1·37; 95% CI: 1·10, 1·71, P= 0·005).
Discussion
In the present cohort of postmenopausal women we have shown
for the first time that a pro-inflammatory diet may be associated
with an increase in a marker of carotid atherosclerosis (CCA–IMT),
as well as increased relative hazards of 15-year ASVD, and IHD-
related mortality in women over the age of 70 years with high DII
score. There was also a borderline significant association
(P=0·05) between DII and CVA-related mortality.
As postmenopausal women are at a higher risk of CVD than
premenopausal women(25), it is critical to investigate potential
modifiable risk factors for CVD in such a population. Diet is one
of the most important and potentially modifiable of these risk
factors. A Western-style diet, recognised to be rich in red
and processed meats, sweets, French fries and refined grains,
is positively associated with inflammatory biomarkers(26),
whereas a Mediterranean-style diet, characterised by a high










































Fig. 2. Mean (a) and maximum (b) common carotid artery–intima-media thickness (CCA–IMT) by quartiles (Q) of dietary inflammatory index (DII): Q1 (−6·140,
−1·370); Q2 (−1·371, 0·160); Q3 (0·161, 1·720); Q4 (1·721, 5·800). Values are means, with their standard errors represented by vertical bars analysed by ANCOVA
and adjusted for age, BMI, energy intake, energy expended in physical activity, socioeconomic status, use of low-dose aspirin, use of antihypertensive medication, use
of statins, current or previous smoking, prevalent atherosclerotic vascular disease and treatment. Linear trend was assessed by a linear regression model (a: P= 0·01;
b: P< 0·01). * Significantly different with Bonferroni adjustment for multiple comparisons (P< 0·05).
Table 4. Associations between dietary inflammatory index (DII), measured at baseline, and moderate-severe atherosclerotic plaque measured at year 3,
Longitudinal Study of Aging in Women, Western Australia, 1998–2013
(Odds ratios and 95% confidence intervals)
Age adjusted Multivariable adjusted*
Characteristics Cases (n) Non-cases (n) OR 95% CI P OR 95% CI P
Continuous DII score 137 889 1·00 0·92, 1·09 0·94 1·00 0·90, 1·12 0·95
DII Q1 36 228 1·00 Ref. 1·00 Ref.
DII Q2 32 227 0·90 0·54, 1·50 0·69 0·98 0·56, 1·7 0·94
DII Q3 34 222 0·99 0·60, 1·63 0·96 0·99 0·54, 1·81 0·97
DII Q4 35 212 1·04 0·63, 1·72 0·88 1·09 0·56, 2·09 0·81
Ref., referent values. Quartiles (Q) of DII: Q1 (−6·140, −1·370); Q2 (−1·371, 0·160); Q3 (0·161, 1·720); Q4 (1·721, 5·800).
* Binary logistic regression models were multivariable adjusted for age, BMI, energy intake, energy expended in physical activity, socioeconomic status, use of low-dose aspirin, use
of antihypertensive medication, use of statins, current or previous smoking, prevalent atherosclerotic vascular disease and treatment.
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fish, is linked with lower levels of inflammatory biomarkers(3).
Investigating the inflammatory effects of individual foods or iso-
lated nutrients can misrepresent in vivo effects, as these con-
stituents are usually ingested along with other foods or as part of a
whole food matrix. In this study, the DII score was used to reflect
the overall inflammatory potential of the participants’ diet. Pre-
vious studies have demonstrated significant positive associations
between DII score and other inflammatory biomarkers such as
high-sensitivity CRP(5,18,27) and IL-6(5,18,28,29).
Arterial wall thickening, stimulated by low-grade systemic
inflammation, underlies many CVD events(9). CCA–IMT, a
measure of arterial wall thickness, is an independent predictor
of CHD(12) and stroke(30), even after adjustment for traditional
risk factors. To our knowledge, this is the first study to explore
the relationship of DII score with sub-clinical atherosclerosis.
We demonstrated that a 1 SD increase in DII score was asso-
ciated with a 0·013-mm higher mean CCA–IMT and a 0·016-mm
higher maximum CCA–IMT. The observed differences in CCA–IMT
may be clinically important as a 0·03-mm increase per year
in CCA–IMT confers a relative risk of 2·2 (95% CI 1·4, 3·6) for
a coronary event(31).
In the present study, the risk of cardiovascular mortality
increased progressively with each quartile of DII score. In
contrast to our multivariable-adjusted model results showing an
increase in the risk of ASVD- CVA- and IHD-related mortality, a
similar analysis performed in a population of middle-aged
Australian women produced null results(32). In that study there
was a suggestion of increased risk with a higher DII score and
the authors suggest that the large CI indicated a lack of power
rather than a lack of association. In the Seguimiento Universidad
de Navarra (SUN) cohort in Spain, the multivariable-adjusted HR
for cardiovascular events (myocardial infarction, stroke or
cardiovascular death) for participants in the highest v. the
lowest quartile of the DII score was 2·03 (95% CI 1·06, 3·88)(33).
This association was attenuated and became non-significant after
excluding participants with chronic aspirin intake. In the present
study, multivariable adjustment included aspirin intake and did
not significantly weaken the observed relationships between
DII score and mortality. Three other prospective cohort studies
by Shivappa et al. have found positive associations between
DII score and CVD mortality(6–8).
Strengths of the present study include its prospective design
with extended period of follow-up and use of the literature-
derived DII which has been validated with a variety of
inflammatory markers(5,18,28,29). We had access to detailed
information on lifestyle and cardiovascular risk factors for study
participants as well as a validated measure of our primary
outcome, CCA–IMT. Furthermore, adjusting for a large range of
confounding factors did not significantly attenuate the observed
relationship between DII and CCA–IMT.
We also acknowledge several limitations of our study. The
number of deaths experienced was relatively low. Although we
were able to detect a relationship between DII score and ASVD-
and IHD-related mortality, the limited number of CVA-related
deaths may have impaired our ability to detect significant dif-
ferences between the highest and lowest quartile of DII score.
Second, the DII score was calculated from only one FFQ, which
does not provide us with information on any change in dietary
pattern throughout follow-up. We recognise that the evidence
for causality for the relationship of DII with CCA–IMT in this
study is weakened by not having CCA–IMT measures at the
same time as the DII assessment. In this regard, the association
Table 5. Associations between dietary inflammatory index (DII) and mortality from multivariate Cox proportional hazards models, Longitudinal Study of
Aging in Women, Western Australia, 1998–2013
(Hazards ratios (HR) and 95% confidence intervals)
Age adjusted Multivariable adjusted*
Characteristics n (%) Person-years HR 95% CI P HR 95% CI P
ASVD mortality
Continuous DII score† 20·7 16 947 1·24 1·10, 1·41 <0·01 1·36 1·15, 1·60 <0·01
DII Q1 16·9 4368 1·00 Ref. <0·01‡ 1·00 Ref. <0·01‡
DII Q2 18·7 4193 1·22 0·85, 1·75 1·31 0·90, 1·93
DII Q3 21·5 4314 1·36 0·95, 1·93 1·39 0·92, 2·12
DII Q4 25·5 4072 1·72 1·22, 2·42 2·02 1·30, 3·13
CVA mortality
Continuous DII score 8·2 16 947 1·20 0·99, 1·46 0·07 1·30 1·00, 1·69 0·05
DII Q1 8·6 4368 1·00 Ref. 0·08‡ 1·00 Ref. 0·07‡
DII Q2 5·2 4193 0·66 0·36, 1·21 0·73 0·39, 1·37
DII Q3 8·0 4314 0·99 0·58, 1·68 1·08 0·57, 2·04
DII Q4 1·1 4072 1·46 0·89, 2·40 1·76 0·92, 3·40
IHD mortality
Continuous DII score 11·5 16 947 1·16 0·99, 1·37 0·07 1·40 1·13, 1·75 <0·01
DII Q1 8·9 4368 1·00 Ref. 0·07‡ 1·00 Ref. <0·01‡
DII Q2 12·2 4193 1·52 0·94, 2·45 1·87 1·13, 3·10
DII Q3 12·6 4314 1·52 0·94, 2·44 1·96 1·11, 3·45
DII Q4 12·3 4072 1·58 0·98, 2·56 2·51 1·37, 4·62
ASVD, atherosclerotic vascular disease; Ref., referent values; CVA, cerebrovascular disease; IHD, ischaemic heart disease. Quartiles of DII: Q1 (−6·140, −1·370); Q2 (−1·371, 0·160);
Q3 (0·161, 1·720); Q4 (1·721, 5·800).
* Cox proportional hazards models were multivariable adjusted for age, BMI, energy intake, energy expended in physical activity, socioeconomic status, use of low-dose aspirin, use
of antihypertensive medication, use of statins, current or previous smoking, prevalent ASVD and treatment.
† Calculated per SD (2·13 units) increase in DII.
‡ P value for trend.
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between the two measures (DII and CCA–IMT) more closely
resembles evidence from a cross-sectional design rather than
a study prospective design. A strong correlation was found
between the DII score calculated from the baseline FFQ and the
DII score calculated from a second FFQ completed at
60 months (r 0·51, P< 0·001). Given that CCA–IMT is a measure
of generalised atherosclerosis, a strong predictor of ASVD
mortality, and DII was associated with both CCA–IMT and
ASVD deaths; it is most likely that direction of the association
between DII and the atherosclerotic process was causal rather
than either inverse or bi-directional. Finally, the present study
population was limited to women over the age of 70 years and
caution should be taken when extrapolating these results to
men and younger women.
Conclusions
In the present cohort we found that postmenopausal women
who consumed a more pro-inflammatory diet, reflected by a
higher DII score were at an increased risk of dying from ASVD,
specifically ischaemic CVA or IHD. We also have shown for the
first time that a pro-inflammatory diet is linearly associated with
sub-clinical atherosclerosis. This supports the hypothesis that a
pro-inflammatory diet increases systemic inflammation leading
to the development and progression of atherosclerosis. This
could then result in a higher risk of mortality from heart disease
or stroke.
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Fig. 3. (a) Atherosclerotic vascular disease (n 269), (b) ischaemic cerebrovascular
disease (n 107) and (c) ischaemic heart disease (n 150) survival outcomes for
quartiles (Q) of dietary inflammatory index (DII). Multivariable-adjusted Cox
regression model included age, BMI, energy intake, energy expended in physical
activity, socioeconomic status, use of low-dose aspirin, use of antihypertensive
medication, use of statins, current or previous smoking, prevalent atherosclerotic
vascular disease and treatment. HR, hazard ratios; a: , DII Q1 (−6·140,
−1·370) – referent; , DII Q2 (−1·371, 0·160) – HR 1·31; 95% CI 0·90, 1·93,
P=0·16; , DII Q3 (0·161, 1·710) – HR 1·39; 95% CI 0·92, 2·12, P=0·12;
, DII Q4 (1·711, 5·800) – HR 2·02; 95% CI 1·30, 3·13, P<0·01. b: , DII
Q1 (−6·140, −1·370) – referent; , DII Q2 (−1·371, 0·160) – HR 1·73; 95% CI
0·39, 1·37, P=0·32; , DII Q3 (0·161, 1·710) – HR 1·08; 95% CI 0·57, 2·04,
P=0·81; , DII Q4 (1·711, 5·800) – HR 1·76; 95% CI 0·92, 3·04, P=0·09. c:
, DII Q1 (−6·140, −1·370) – referent; , DII Q2 (−1·371, 0·160) – HR
1·87; 95% CI 1·13, 3·10, P=0·02; , DII Q3 (0·161, 1·710) – HR 1·96; 95% CI
1·11, 3·45, P=0·02; , DII Q4 (1·711, 5·800) – HR 2·51; 95% CI 1·37, 4·62,
P<0·01.
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